SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Quipt Home Medical Corp. (QIPT) , 前瞻盈利收益率 42.74%.
本页证实的标准:
- VALUE (10/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($1.70, 53.4%).
- 前瞻市盈率 2.3
- 分析师共识目标价 $1.70 (-53.4% 下行风险) — 分析师认为当前价格水平存在明显下行风险。
SharesGrow 综合评分： 30/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
10/100
Price-to-Earnings & upside
Proven by this page
✗
健康
33/100
Debt-to-Equity & liquidity
→ Health
估值概览 — QIPT
估值倍数
P/E (TTM)0.0
前瞻 P/E2.3
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.46
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.25
前瞻 EPS（预估）$1.56
每股账面价值$0.00
每股营收$7.89
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield42.74%
股息收益率0.00%
分析师目标价$1.70 (-53.4%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-3.23 |
$73.27M |
$-57.37M |
-78.3% |
| 2017 |
$-1.02 |
$61.56M |
$-19.15M |
-31.1% |
| 2018 |
$0.72 |
$59.49M |
$14.51M |
24.4% |
| 2019 |
$-0.27 |
$61.16M |
$-5.58M |
-9.1% |
| 2020 |
$-0.17 |
$72.64M |
$-4.57M |
-6.3% |
| 2021 |
$-0.20 |
$102.35M |
$-6.17M |
-6% |
| 2022 |
$0.13 |
$139.86M |
$4.84M |
3.5% |
| 2023 |
$-0.07 |
$211.68M |
$-2.78M |
-1.3% |
| 2024 |
$-0.16 |
$245.92M |
$-6.76M |
-2.8% |
| 2025 |
$-0.25 |
$341.4M |
$-10.7M |
-3.1% |
